NOT KNOWN FACTUAL STATEMENTS ABOUT AGO TUMOR

Special pathological reporting is important in individuals undergoing neoadjuvant systemic therapy (NST). There exist no less than 5 different reporting scores for that quality of remission just after NST; A few of these, however, are only validated for inflammatory breast most cancers (e.Molecular pathology for classification of tumors and for eff